Clinical Research Directory
Browse clinical research sites, groups, and studies.
Palbociclib Induced Neutropenia; Risk Factors and Treatment Outcome in Metastatic Breast Cancer Patients
Sponsor: Assiut University
Summary
Aim of the study to assess the neutropenia induced by Palbociclib in patient receiving Palbociclib in combination with hormonal treatment as first-line therapy in metastatic hormone receptor- positive HER2 negative breast cancer. To evaluate the risk factors for occurrence of neutropenia and treatment outcome as 2 years PFS and OS.
Key Details
Gender
All
Age Range
Any - Any
Study Type
OBSERVATIONAL
Enrollment
54
Start Date
2023-11
Completion Date
2026-12
Last Updated
2023-10-11
Healthy Volunteers
No
Conditions
Interventions
Palbociclib
The investigator will follow the patients after starting treatment to follow and observe the outcome of the treatment side effects and risk factors
Locations (1)
Asmaa Imam Ahmed
Al Madīnah, AL, Saudi Arabia